Pregnancy and Birth

Members of the ACIP voted on Friday to recommend Pfizer’s maternal bivalent RSVpreF vaccine to protect newborns from severe RSV illness.

Results from a new study suggest that postnatal SSRI treatment may be beneficial in the long term for both women with postpartum depression and their children.

The FDA approved Abrysvo for use in pregnant individuals to prevent LRTD and severe LRTD caused by RSV in infants from birth through 6 months of age.

The US FDA approved zuranolone 50 mg as the first oral, once-daily treatment for postpartum depression in adults.

The US FDA approved norgestrel as the first daily oral contraceptive to be available over the counter, without a prescription.

Opill, a progestin-only oral contraceptive, if approved by the FDA, would be the first an only form of birth control in the US available without a physician's prescription.

Women with prior HC-associated depression had a higher risk of developing a depressive episode during pregnancy and postpartum than women with non-HC-associated depression.

Your daily dose of clinical news you may have missed.

Pregnant women with prenatal depression were found to be more likely to be diagnosed with new CVD within 2 years of delivery than those without depression.

ACC 2023. Increasing rates of adverse pregnancy outcome over the last decade are largely attributable to a woman’s health status before she gets pregnant, rather than age, according to new research.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

Findings showed that greater concordance to the Mediterranean diet was linked to a 21% lower risk of developing any adverse pregnancy outcomes.

Drug overdose deaths increased approximately 81% among pregnant and postpartum women in the US from 2017 to 2020, according to new research.

Analysis of women who did not have high blood pressure while pregnant found that 1 in 10 were diagnosed with hypertension in the year after delivery.

Your daily dose of clinical news you may have missed.

Your daily dose of clinical news you may have missed.

AHA 2022: Study authors say more research is needed to investigate the impact of targeting social determinants of health to improve cardiometabolic risk and mortality in pregnant women.

Black women seeking fertility care were less likely to report getting COVID-19 vaccine and were unsatisfied with how major health care systems handled the pandemic.

Top-line data from the EVOGUARD clinical trial examining the efficacy of Phexxi for the prevention of chlamydia and gonorrhea are expected in October 2022.

Results from a phase 2b trial showed that a bivalent RSV prefusion F protein-based vaccine was safe and led to higher neutralizing antibody responses in pregnant women.

ACC 2022: Use of antihypertensive therapy in pregnant women was associated with better pregnancy outcomes, such as preeclampsia and fetal or neonatal death.

Researchers also found that women with migraine with aura had a higher risk of preeclampsia than those with migraine without aura.

The CDC now recommends that pregnant and breastfeeding individuals get vaccinated against COVID-19.

From obesity to pneumococcal disease, we have picked the top 6 FDA-approved drugs every primary care physician should know about from the second quarter.

The end of another quarter means a new list of FDA-approved drugs for primary care. Which ones should you know about? Click through to find out. 

Here: at least 5 tips on hypertensive disorders during pregnancy.

They often willingly accept pre-exposure prophylaxis when offered.

NSAIDs may impair fertility in women with mild musculoskeletal pain. Damage is reversible once NSAIDs are discontinued, according to a new study.

Pseudosac with ectopic pregnancy, palmar erythema, pemphigoid gestationis, abdominal wall hematoma, dermatomyositis, livedo reticularis-visual presentations of health problems that occur frequently, or exclusively, in women.